Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-951"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-951"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-9502
lpv:speaker	lp:Alfredo Pallone2
lpv:spokenAs	member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 substitute; Delegation for relations with Canada (2009-09-16--2014-06-30)3 member; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3 member; EPP (2009-11-25--2014-06-30)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (2009-09-16--2014-06-30)3 substitute; LIBE (2009-07-16--2012-01-18)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-16)3
lpv:translated text	"Since it focuses on the patient’s right to information, I fully support the report, which includes some important innovations. The first concerns the Internet: Parliament intends to make consumers aware of the risks of buying drugs online while also pushing for the proposal of ad hoc legislation on this selling method. The second concerns the ban on advertising prescription-only drugs, because it is important to draw a distinction between generic and non-generic drugs, not only from the viewpoint of information to be given to patients but above all with regard to compliance with good practice in the manufacturing of active substances, particularly outside Europe."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph